Brensocatib Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04817332STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19